Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $0.16, up from yesterday’s close by -2.88%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.
Does this stock stack up well when compared to its peers in the space? Let’s take a look. Rexahn Pharmaceuticals, Inc. (RNN) currently trades with a market capitalization of $38.43M.
The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For RNN, the company currently has $21.81M of cash on the books, which is offset by $0.00 current liabilities. You can get a sense of how sustainable that is by a levered free cash flow of $-9.87M over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of -3.6 on a per share basis this quarter. Perhaps, that suggests something about why 4.80% of the outstanding share supply is held by institutional investors.
As most professionals know, technical analysis can offer critical insights into what smart money and insiders think about a stock’s prospects going forward. Looking at the stock’s movement on the chart, Rexahn Pharmaceuticals, Inc. recorded a 52-week high of 0.42. It is now trading 0.25 off that level. The stock is trading 0.16 its 50-day moving average by -0.01. The stock carved out a 52-week low down at 0.13.
In recent action, Rexahn Pharmaceuticals, Inc. (RNN) has made a move of unch over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 66.78, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 215.61M with 1.34% sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of RNN.